Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholecalciferol in IBD (5C-study)
NCT04991324Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in inflammatory bowel disease (IBD), sponsored by University Hospital Basel. Started Sep 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NCT04991324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04991324.